3D mammography detected 34% more breast cancers in screening
After screening 15 000 women over a period of five years, a major clinical study in Sweden has shown that 3D mammography, or breast tomosynthesis, detects over 30% more cancers compared to traditional mammography – with a majority of the detected tumours proving to be invasive cancers. The extensive screening study was conducted by Lund University and Skåne University Hospital in Sweden, and the results are now published in the reputable journal Lancet Oncology.
Using breast tomosynthesis (3D screening) in the image to the left (one of about 50 thin cross-sectional image slices of the breast), you can see an approximately 1 cm-large tumour that is not clearly visible on the mammography image on the right, even though the breast does not contain particularly dense tissue. Image: Skåne University Hospital in Malmö
“With breast tomosynthesis, 34 per cent more cancer tumours were detected compared to the current standard mammography screening. At the same time, we were able to reduce the compression of the breast during examination, something that may encourage more women to participate in screening”, explains Sophia Zackrisson, associate professor at Lund University and radiologist at Skåne University Hospital (SUS), continuing:
“We did, however, need to call back a few more women for additional examinations compared to traditional mammography. We needed to confirm that these women did not have cancer, as this method finds more structures in the breast in general. So, there was an increased call-back rate.”
In traditional mammography screening, all breast tissue is captured in a single image. Breast tomosynthesis, on the other hand, is three-dimensional and works according to the same principle as what is known as tomography. This means that several low-dose x-ray images are taken of the breast from different angles, which are reconstructed by a computer to show thin layers of the breast. With more and improved image informationand less overlapping tissue structures, the chance of detecting tumours increases. Further, the radiation dose may be lowered in certain circumstances.
“There is a need to improve screening for many women, and breast tomosynthesis is clearly the most appropriate method to transition to in breast cancer screening. Breast tomosynthesis will be introduced, it’s just a question of when and to what extent”, says Sophia Zackrisson.
Breast tomosynthesis is already used at Skåne University Hospital, among other places, to investigate suspected breast cancer. Prior to a possible large-scale introduction in the general breast cancer screening programme, the research team is now conducting a cost-benefit study.
All types of screening involve a risk of overdiagnosis, which in turn may lead to unjustified treatments. Therefore, the research team, in collaboration with their European colleagues, will conduct a metastudy in which they will aggregate and analyse their collective research results.
The lack of radiologists who can review the increased image material generated by 3D methods presents a further challenge before large-scale introduction. However, the method used at Skåne University Hospital may be more efficient than those previously examined in international studies. In Skåne, only the 3D method has been used whereas other studies have combined 3D with traditional mammography screening. This leads to more image material and a higher radiation dose.
“We have shown that we can achieve the same result with a simpler and perhaps even better method”, says Sophia Zackrisson.
In the future, parts of the image review in connection with breast tomosynthesis may be automated with the help of computers, but it will take time. There is currently a lack of appropriate ready-to-use and tested software. Studies are underway, including in Sophia Zackrisson’s research team.
About the study:
Close to 15 000 women participated in the screening study conducted at Skåne University Hospital in Malmö in 2010–2015. The study’s midway results were published three years ago. The new results published in the reputable journal Lancet Oncology confirm that breast tomosynthesis is superior to today’s mammography screening in the detection of cancer tumours.
Publication: One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study
Sophia Zackrisson, senior lecturer and associate professor at the Department of Translational Medicine, Lund University, and radiologist at Skåne University Hospital in Malmö
+46 40 33 87 97, +46 736 87 41 49
sophia [dot] zackrisson [at] med [dot] lu [dot] se